Mounjaro®
Starting from £179.99/mo
Start journey Learn moreThe most important question to ask before starting Mounjaro is not just whether you qualify, but whether anything else you take could be affected by it. Mounjaro (tirzepatide) slows gastric emptying, which changes how quickly other medicines are absorbed, and that can have real consequences depending on what you are already on. This page covers the key interactions, the medicines requiring the most attention, and what your prescriber will be looking at when they review your case. Mounjaro is a prescription-only medicine; a GPhC-registered prescriber must assess your full medication history before treatment is considered appropriate for you.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
Plenty of people starting Mounjaro assume the interactions list is short and mainly concerns insulin. That assumption can cause real problems. Because tirzepatide slows gastric emptying as part of how it works, it has the potential to affect the absorption of almost any oral medicine you take, not just those used in diabetes management. The rate at which a tablet or capsule reaches the small intestine changes, and for some medicines that timing matters enormously.
The drugs that demand the most attention are those where a small change in blood levels can either stop working or cause harm. Warfarin sits at the top of that list. If your INR drifts because warfarin is absorbed differently, the consequences can be serious. The same principle applies to certain antiepileptics, some thyroid medicines, and narrow-therapeutic-index drugs generally. Your prescriber will ask about every medicine you take, not just the obvious ones, and that conversation is worth taking seriously. A full picture of your medication history is part of what the clinical assessment at nume (sorry, at Mounjaro) covers at consultation.
If you want a thorough grounding in what tirzepatide is and how its mechanism produces these effects, the overview of GLP-1 and GIP receptor agonists is a useful starting point. The NHS also maintains a dedicated patient-level page for tirzepatide that lists known interactions in plain language.
This is the interaction that surprises people most. MHRA guidance, echoed by NHS England, is clear: women taking oral contraceptives should use an additional non-oral method of contraception (condoms are the practical choice) for the first four weeks of Mounjaro treatment and for four weeks after every dose increase. The concern is that slower gastric emptying may reduce how reliably the pill is absorbed, potentially lowering its effectiveness.
There is no equivalent evidence of this effect with semaglutide (Wegovy), so this is a tirzepatide-specific consideration. Many people don't realise this applies each time the dose steps up, not just at the start. So if you move from 5mg to 7.5mg, the four-week non-oral rule restarts. It's the sort of detail that's easy to miss if you receive your prescription without a proper clinical briefing.
NHS England also advises that women using HRT should discuss whether transdermal preparations (patches or gels rather than tablets) are preferable while on tirzepatide, for the same absorption reason. The interactions section of our Mounjaro guidance covers the contraception and HRT questions in more detail.
For anyone already managing type 2 diabetes, this is the area prescribers watch most carefully. Mounjaro itself lowers blood glucose as part of its dual GIP and GLP-1 action. When it is taken alongside insulin or sulphonylureas (a class of oral diabetes tablets that stimulate insulin release), the combined effect can push blood sugar too low.
The BNF's interaction guidance for tirzepatide and the BNF's tirzepatide entry flags this combination as requiring dose review and closer glucose monitoring. In clinical practice, a prescriber managing someone on insulin who wishes to start Mounjaro will usually plan a dose reduction of the insulin before, or shortly after, starting tirzepatide, rather than waiting for symptoms of a hypo to appear. Self-adjusting insulin without clinical guidance is not safe; this needs direct prescriber input before anything changes.
The practical message: if you take any medicine for blood sugar control, bring your full list of doses and testing readings to your consultation. It lets the prescriber make a safe plan from the outset, rather than firefighting later. You can read more about how Mounjaro works in combination with other treatments on the Mounjaro interactions page.
Beyond the categories above, a handful of other medicine types are worth flagging explicitly. Levothyroxine (used for an underactive thyroid) is typically taken first thing in the morning on an empty stomach (some people also take the Wegovy tablet at that moment) and prescribers will want to think through the timing carefully to avoid any absorption conflict. Oral antibiotics, some antifungals and certain blood pressure medicines may also behave differently when gastric transit time is extended.
Alcohol is not a contra-indicated drug interaction, but it does compound the nausea that is common in the early weeks of treatment, and it carries an independent risk of hypoglycaemia in people on blood-sugar-lowering medicines, so it's a sensible practical point to raise. Medicines bought over the counter (including ibuprofen, which is used widely) should also be mentioned, since NSAIDs add to the risk of GI discomfort and can mask symptoms like stomach pain that would otherwise prompt someone to seek help sooner.
Before starting any new treatment, prescription or over-the-counter, updating your prescriber is the right habit to build. If you are considering starting Mounjaro for the first time, the full guide to what medications to avoid with Mounjaro sets out the complete clinical picture, and the Mounjaro overview gives broader context on what the treatment involves. For anyone weighing up whether to proceed, you can also explore the available weight-loss treatments to see how tirzepatide sits alongside the other licensed options.
A conversation with a prescriber who knows your full medication history is the only safe way to establish whether Mounjaro is right for you. Our prescribers review every consultation personally — one of them will read your answers the same day you submit, not a piece of software running keyword checks. If you have a complicated medication list, being thorough in that consultation is the single most useful thing you can do. Speak to our prescribers when you are ready to take that step.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.